How Does FDI Screening Impact M&A Transactions in France?

⸻

Can a well-structured M&A transaction fail in France due to FDI screening risk?

M&A in France is not solely driven by valuation, synergies and financial structuring, particularly when a foreign investor targets a business operating in a sensitive or strategic sector.

In such transactions, FDI screening becomes a central component of deal execution, shaping not only regulatory approval but also negotiation dynamics, timing and overall feasibility.

FDI screening should therefore not be treated as a post-signing regulatory step, but as a core deal parameter that directly influences whether a transaction can proceed, under what conditions, and at what cost.

Understanding how M&A in France FDI screening interacts is essential for investors, advisors and sellers involved in cross-border transactions.

• FDI screening can materially impact M&A in France by affecting deal execution, timeline, valuation and transaction structure. In sensitive transactions, regulatory perception may be as decisive as legal compliance, creating significant execution risk.

⸻

FDI screening as a core deal parameter in French M&A

In cross-border transactions, FDI screening must be integrated into the deal logic from the outset, as it directly affects execution risk and transaction optionality.

It can:

• delay or suspend closing beyond anticipated timelines

• impose conditions affecting governance, access to information or operations

• require structural adjustments to mitigate regulatory concerns

• ultimately prevent completion despite legal feasibility

As a result, M&A in France increasingly requires a dual analysis combining financial rationale and regulatory acceptability.

⸻

When does FDI screening become a critical deal issue?

FDI screening risk typically arises when three cumulative factors are present:

• a non-French or non-EU investor

• an acquisition of control or decisive influence

• a target active in a sensitive or strategic sector

However, in practice, regulatory scrutiny often extends beyond strictly defined thresholds.

Transactions may attract attention when:

• the target operates at the frontier of sensitive activities

• the investor profile raises strategic or geopolitical considerations

• the transaction occurs in a politically sensitive context

This creates a layer of uncertainty that cannot be captured by a purely legal analysis.

⸻

The impact on deal structuring and valuation

FDI screening frequently leads to adjustments that directly affect transaction economics and governance.

Typical implications include:

• governance constraints (board composition, veto rights, control limitations)

• restrictions on access to sensitive data or technologies

• ring-fencing of strategic activities within the target

• operational commitments relating to continuity or localization

These constraints can influence valuation, introduce execution risk discounts and affect the overall attractiveness of the deal.

This may translate into valuation adjustments, price renegotiations or the introduction of regulatory risk discounts directly linked to approval uncertainty.

⸻

FDI screening and execution timeline risk

One of the most underestimated aspects of M&A in France is the variability of execution timelines driven by FDI review.

While statutory deadlines exist, the effective timeline depends on:

• the completeness and quality of the filing

• the complexity and sensitivity of the target’s activities

• the intensity of interactions with the administration

• the potential negotiation of commitments or remedies

Delays may have direct consequences on financing conditions, exclusivity periods and long-stop dates, thereby impacting deal certainty.

In certain cases, prolonged uncertainty or stringent conditions may lead parties to abandon the transaction altogether.

⸻

Negotiation dynamics under regulatory constraints

FDI screening reshapes negotiation dynamics between buyers and sellers by introducing regulatory uncertainty into the transaction.

It may:

• shift leverage depending on regulatory exposure

• affect pricing through risk allocation mechanisms

• introduce conditions precedent linked to regulatory approval

• require detailed contractual provisions on risk sharing

In sensitive transactions, regulatory risk becomes a central variable alongside valuation and strategic rationale.

⸻

The gap between legal feasibility and deal acceptability

A transaction may fall within the legal framework and still face significant execution risk.

This reflects a structural feature of M&A in France:

Approval depends not only on regulatory qualification, but on whether the transaction is considered acceptable in light of national interests, industrial policy and strategic considerations.

Anticipating this gap is critical to securing deal execution.

⸻

How experienced investors manage FDI risk

Sophisticated investors integrate FDI considerations into their deal strategy at a very early stage, often before formal negotiations begin.

They typically:

• conduct early regulatory risk assessments

• identify sensitivity beyond formal sector classification

• adapt deal structuring to regulatory expectations

• engage proactively with authorities when appropriate

This approach allows them to preserve optionality, manage uncertainty and secure execution conditions more effectively.

⸻

Diagnostic — Is Your M&A Transaction Exposed?

Before moving forward, assess the following:

• Is the investor foreign or linked to non-EU interests?

• Does the target operate in a potentially sensitive or strategic activity?

• Does the transaction grant control or significant influence?

• Could the deal raise political, industrial or sovereignty concerns?

If the answer to several of these questions is yes, your transaction is likely exposed to FDI-driven execution risk.

Anticipate FDI risk before it impacts your deal.

Contact Relians to assess your transaction, quantify regulatory risk and secure deal execution from the outset.

⸻

“In France, M&A success is not determined solely by financial structuring or legal compliance, but by whether a transaction is considered strategically acceptable by public authorities.”